Shockwave Medical (SWAV) Prices 2.48M Share Common Offering at $36.25/Sh

Shockwave Medical, Inc. (NASDAQ: SWAV) today announced the pricing of its public offering of 2,481,781 shares of its common stock at a price to the public of $36.25 per share. All of the shares are being offered by Shockwave. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Shockwave, are expected to be approximately $90.0 million. The offering is scheduled to close on November 19, 2019, subject to the satisfaction of customary closing conditions. The underwriters for the offering also have a 30-day option to purchase up to an additional 372,267 shares of Shockwave’s common stock at the price to the public, less underwriting discounts and commissions. Shockwave’s common stock is listed on the Nasdaq Global Select Market under the ticker symbol “SWAV.”

Morgan Stanley and BofA Securities are acting as joint lead book-running managers for the offering. Wells Fargo Securities and Canaccord Genuity are acting as co-managers for the offering.

You May Also Be Interested In

• Morgan Stanley Private Credit Fund Caps Redemptions At 5%
• Aflac (AFL) files mixed shelf
• Gelum Resources closes $4.3M private placement, hires geophysics firm